Business Description
Avidity Biosciences Inc
NAICS : 541714
SIC : 2834
ISIN : US05370A1088
Share Class Description:
RNA: Ordinary SharesDescription
Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 209 | |||||
| Equity-to-Asset | 0.92 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 17.48 | |||||
| Beneish M-Score | -2.47 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -25.2 | |||||
| 3-Year EBITDA Growth Rate | -16.5 | |||||
| 3-Year EPS without NRI Growth Rate | -12.4 | |||||
| 3-Year FCF Growth Rate | 1.4 | |||||
| 3-Year Book Growth Rate | -8.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | -4.84 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 68.57 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 11.51 | |||||
| 9-Day RSI | 20.94 | |||||
| 14-Day RSI | 28.02 | |||||
| 3-1 Month Momentum % | 25.87 | |||||
| 6-1 Month Momentum % | 31.38 | |||||
| 12-1 Month Momentum % | 570.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 17.76 | |||||
| Quick Ratio | 17.76 | |||||
| Cash Ratio | 17.39 | |||||
| Days Sales Outstanding | 48.34 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -28.3 | |||||
| Shareholder Yield % | -28.32 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -3209.35 | |||||
| Net Margin % | -2772.45 | |||||
| FCF Margin % | -1863.31 | |||||
| ROE % | -30.66 | |||||
| ROA % | -27.28 | |||||
| ROIC % | -590.03 | |||||
| 3-Year ROIIC % | -350.89 | |||||
| ROC (Joel Greenblatt) % | -1998.68 | |||||
| ROCE % | -34.1 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 289.94 | |||||
| PB Ratio | 2.57 | |||||
| Price-to-Tangible-Book | 2.57 | |||||
| EV-to-EBIT | -7.54 | |||||
| EV-to-Forward-EBIT | -1.3 | |||||
| EV-to-EBITDA | -7.6 | |||||
| EV-to-Forward-EBITDA | -1.32 | |||||
| EV-to-Revenue | 241.86 | |||||
| EV-to-Forward-Revenue | 179.37 | |||||
| EV-to-FCF | -12.98 | |||||
| Price-to-GF-Value | 3.54 | |||||
| Price-to-Net-Current-Asset-Value | 2.6 | |||||
| Price-to-Net-Cash | 2.66 | |||||
| Earnings Yield (Greenblatt) % | -13.26 | |||||
| FCF Yield % | -4.86 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RNA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Avidity Biosciences Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 10.117 | ||
| EPS (TTM) ($) | -2.89 | ||
| Beta | 1.08 | ||
| 3-Year Sharpe Ratio | 0.58 | ||
| 3-Year Sortino Ratio | 1.24 | ||
| Volatility % | 74.8 | ||
| 14-Day RSI | 28.02 | ||
| 14-Day ATR ($) | 2.506024 | ||
| 20-Day SMA ($) | 39.9585 | ||
| 12-1 Month Momentum % | 570.5 | ||
| 52-Week Range ($) | 7.88 - 56 | ||
| Shares Outstanding (Mil) | 119.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Avidity Biosciences Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Avidity Biosciences Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Avidity Biosciences Inc Frequently Asked Questions
What is Avidity Biosciences Inc(RNA)'s stock price today?
The current price of RNA is $32.49. The 52 week high of RNA is $56.00 and 52 week low is $7.88.
When is next earnings date of Avidity Biosciences Inc(RNA)?
The next earnings date of Avidity Biosciences Inc(RNA) is 2025-02-28 Est..
Does Avidity Biosciences Inc(RNA) pay dividends? If so, how much?
Avidity Biosciences Inc(RNA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers